Published in Cancer on August 15, 2005
Patient Navigation and Financial Incentives to Promote Smoking Cessation | NCT02351609
Patient navigation: state of the art or is it science? Cancer (2008) 5.62
National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer (2008) 4.64
A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med (2009) 3.48
Patient navigation: an update on the state of the science. CA Cancer J Clin (2011) 3.26
The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health (2007) 3.04
A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry (2009) 2.90
Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer (2008) 2.60
Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev (2012) 1.76
Evaluation of Patient Navigation in a Community Radiation Oncology Center Involved in Disparities Studies: A Time-to-Completion-of-Treatment Study. J Oncol Pract (2008) 1.75
The role of patient navigators in eliminating health disparities. Cancer (2011) 1.73
A multilevel intervention to promote colorectal cancer screening among community health center patients: results of a pilot study. BMC Fam Pract (2009) 1.67
The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev (2012) 1.66
Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55
Understanding the processes of patient navigation to reduce disparities in cancer care: perspectives of trained navigators from the field. J Cancer Educ (2011) 1.51
A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med (2011) 1.46
Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med (2010) 1.35
Use of cancer control referrals by 2-1-1 callers: a randomized trial. Am J Prev Med (2012) 1.35
Patient navigation for American Indians undergoing cancer treatment: utilization and impact on care delivery in a regional healthcare center. Cancer (2010) 1.32
A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.28
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer (2009) 1.24
Reducing disparities in the burden of cancer: the role of patient navigators. PLoS Med (2006) 1.24
An investigation into the social context of low-income, urban Black and Latina women: implications for adherence to recommended health behaviors. Health Educ Behav (2011) 1.23
Case management used to optimize cancer care pathways: a systematic review. BMC Health Serv Res (2008) 1.21
Using community-based research methods to design cancer patient navigation training. Prog Community Health Partnersh (2008) 1.21
Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review. J Oncol (2010) 1.19
Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. Am J Public Health (2008) 1.19
Involving American Indians and medically underserved rural populations in cancer clinical trials. Clin Trials (2009) 1.16
Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med (2010) 1.13
Metrics for evaluating patient navigation during cancer diagnosis and treatment: crafting a policy-relevant research agenda for patient navigation in cancer care. Cancer (2011) 1.13
Patient navigation: development of a protocol for describing what navigators do. Health Serv Res (2010) 1.12
Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer (2010) 1.11
Patient perspectives of clinical care and patient navigation in follow-up of abnormal mammography. J Gen Intern Med (2010) 1.09
Culturally targeted patient navigation for increasing african americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2013) 1.09
Promoting access to renal transplantation: the role of social support networks in completing pre-transplant evaluations. J Gen Intern Med (2008) 1.08
A qualitative assessment of community-based breast health navigation services for Southeast Asian women in Southern California: recommendations for developing a navigator training curriculum. Am J Public Health (2010) 1.06
Implementation of culturally targeted patient navigation system for screening colonoscopy in a direct referral system. Health Educ Res (2013) 1.05
Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. Womens Health Issues (2014) 1.03
Innovative approaches to reducing cancer health disparities: the Moffitt Cancer Center Patient Navigator Research Program. J Cancer Educ (2011) 1.03
Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse (2011) 1.03
Cancer health disparities: what we have done. Am J Med Sci (2008) 1.02
Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population. Mayo Clin Proc (2009) 1.02
Testing for statistical discrimination by race/ethnicity in panel data for depression treatment in primary care. Health Serv Res (2008) 0.99
The role of lay health workers in pediatric chronic disease: a systematic review. Acad Pediatr (2013) 0.97
Strategies to increase breast and cervical cancer screening among Hawaiian, Pacific Islander, and Filipina women in Hawai'i. Hawaii Med J (2009) 0.97
Reducing preventable emergency department utilization and costs by using community health workers as patient navigators. J Healthc Manag (2014) 0.97
Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial. J Gen Intern Med (2015) 0.96
Native cancer navigation: the state of the science. Clin J Oncol Nurs (2012) 0.95
Improving chronic illness care for veterans within the framework of the Patient-Centered Medical Home: experiences from the Ann Arbor Patient-Aligned Care Team Laboratory. Transl Behav Med (2011) 0.95
Addressing Cancer Disparities Among American Indians through Innovative Technologies and Patient Navigation: The Walking Forward Experience. Front Oncol (2011) 0.94
A randomized trial: are care navigators effective in connecting patients to primary care after psychiatric crisis? Community Ment Health J (2010) 0.93
Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women. BMC Cancer (2012) 0.93
Primary care after psychiatric crisis: a qualitative analysis. Ann Fam Med (2008) 0.92
Closing the gap: eliminating health care disparities among Latinos with diabetes using health information technology tools and patient navigators. J Diabetes Sci Technol (2012) 0.92
A coping and communication support intervention tailored to older patients diagnosed with late-stage cancer. Clin Interv Aging (2008) 0.92
Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities. Cancer (2012) 0.92
Impact of patient navigation from diagnosis to treatment in an urban safety net breast cancer population. J Cancer (2011) 0.91
Impact of patient navigation on cancer diagnostic resolution among Northwest Tribal communities. J Cancer Educ (2013) 0.90
Managing risk in cancer presentation, detection and referral: a qualitative study of primary care staff views. BMJ Open (2014) 0.90
A pilot test of a peer navigator intervention for improving the health of individuals with serious mental illness. Community Ment Health J (2013) 0.90
Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer (2011) 0.89
Relationship styles and mortality in patients with diabetes. Diabetes Care (2009) 0.89
Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer. J Urol (2014) 0.89
Telephone outreach to increase colon cancer screening in medicaid managed care organizations: a randomized controlled trial. Ann Fam Med (2013) 0.88
A novel community-based study to address disparities in hypertension and colorectal cancer: a study protocol for a randomized control trial. Trials (2013) 0.88
Patient navigators' reflections on the navigator-patient relationship. J Cancer Educ (2014) 0.86
Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project. Health Policy (2010) 0.86
Enhancing Hispanic participation in mental health clinical research: development of a Spanish-speaking depression research site. Depress Anxiety (2013) 0.85
Examining the effect of a patient navigation intervention on outpatient cardiac rehabilitation awareness and enrollment. J Cardiopulm Rehabil Prev (2013) 0.85
Knowledge and behavioral effects in cardiovascular health: Community Health Worker Health Disparities Initiative, 2007-2010. Prev Chronic Dis (2014) 0.85
The role of socioeconomic status in adjustment after ductal carcinoma in situ. Cancer (2010) 0.84
The use of patient navigators to improve cancer care for Hispanic patients. Clin Med Insights Oncol (2011) 0.84
Cervical cancer control for Hispanic women in Texas: strategies from research and practice. Gynecol Oncol (2014) 0.83
An evaluation of the cost-effectiveness of policy navigators to improve access to care for the poor in the Philippines. Health Policy (2009) 0.83
Exploring primary care providers' interest in using patient navigators to assist in the delivery of tobacco cessation treatment to low income, ethnic/racial minority patients. J Community Health (2010) 0.82
Strategies used and challenges faced by a breast cancer patient navigator in an urban underserved community. J Natl Med Assoc (2011) 0.82
An evaluation of cancer survivorship activities across national comprehensive cancer control programs. J Cancer Surviv (2015) 0.82
Unmet needs in immigrant cancer survivors: a cross-sectional population-based study. Support Care Cancer (2013) 0.81
Racial differences and disparities in cancer care and outcomes: where's the rub? Surg Oncol Clin N Am (2012) 0.81
Building a navigation system to reduce cancer disparities among urban Black older adults. Prog Community Health Partnersh (2013) 0.81
Cervical cancer screening: exploring Appalachian patients' barriers to follow-up care. Soc Work Health Care (2014) 0.81
Challenges to replicating evidence-based research in real-world settings: training African-American peers as patient navigators for colon cancer screening. J Cancer Educ (2012) 0.81
Preventing recurrence of thromboembolic events through coordinated treatment in the District of Columbia. Int J Stroke (2011) 0.80
Lay navigator model for impacting cancer health disparities. J Cancer Educ (2014) 0.80
Effect of patient navigation on satisfaction with cancer-related care. Support Care Cancer (2015) 0.79
Decomposing differences in medical care access among cancer survivors by race and ethnicity. Am J Med Qual (2014) 0.79
Peer navigators and integrated care to address ethnic health disparities of people with serious mental illness. Soc Work Public Health (2014) 0.79
A patient navigation intervention for drug-involved former prison inmates. Subst Abus (2014) 0.78
Applying best practices to designing patient education for patients with end-stage renal disease pursuing kidney transplant. Prog Transplant (2015) 0.78
Effects of social injustice on breast health-seeking behaviors of low-income women. Am J Health Promot (2013) 0.78
The process, outcomes, and challenges of feasibility studies conducted in partnership with stakeholders: a health intervention for women survivors of intimate partner violence. Res Nurs Health (2015) 0.78
Qualitative evaluation of a new tobacco cessation training curriculum for patient navigators. J Cancer Educ (2011) 0.77
Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment. Cancer (2015) 0.77
Feasibility, acceptability and preliminary effectiveness of patient advocates for improving asthma outcomes in adults. J Asthma (2013) 0.77
The association between social stressors and drug use/hazardous drinking among former prison inmates. J Subst Abuse Treat (2014) 0.77
Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials. J Oncol Pract (2016) 0.77
The Sooke Navigator project: using community resources and research to improve local service for mental health and addictions. Ment Health Fam Med (2009) 0.76
Navigating the mental health and addictions maze: a community-based pilot project of a new role in primary mental health care. Ment Health Fam Med (2009) 0.76
Lessons Learned From a Randomized Controlled Trial of a Family-Based Intervention to Promote School Functioning for School-Age Children With Sickle Cell Disease. J Pediatr Psychol (2015) 0.76
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Primary care physicians who treat blacks and whites. N Engl J Med (2004) 12.23
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
Care patterns in Medicare and their implications for pay for performance. N Engl J Med (2007) 6.74
The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst (2007) 6.12
Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA (2004) 5.43
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol (2010) 5.21
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist (2013) 4.33
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
How to build and interpret a nomogram for cancer prognosis. J Clin Oncol (2008) 4.24
Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med (2010) 4.11
Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA (2009) 4.04
The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med (2003) 4.01
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol (2008) 3.93
Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol (2006) 3.83
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol (2006) 3.75
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol (2007) 3.60
When you look matters: the effect of assessment schedule on progression-free survival. J Natl Cancer Inst (2007) 3.60
Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med (2009) 3.59
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care (2002) 3.57
Delivery of preventive services to older adults by primary care physicians. JAMA (2005) 3.53
Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol (2011) 3.53
Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol (2005) 3.29
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol (2012) 2.59
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol (2006) 2.32
Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol (2007) 2.04
Rapidity and modality of imaging for acute low back pain in elderly patients. Arch Intern Med (2009) 2.01
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97
Use of information resources by patients with cancer and their companions. Cancer (2004) 1.93
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc (2007) 1.89
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer (2005) 1.86
Cancer screening among patients with advanced cancer. JAMA (2010) 1.82
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care (2009) 1.76
Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol (2011) 1.75
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol (2011) 1.71
Attribution of deaths following cancer treatment. J Natl Cancer Inst (2002) 1.63
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care (2009) 1.62
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. J Natl Cancer Inst (2014) 1.61
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59
Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum (2008) 1.53
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer (2008) 1.53
Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist (2013) 1.52
Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52
A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr (2005) 1.51
Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol (2014) 1.51
Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist (2011) 1.50
Reliability of adverse symptom event reporting by clinicians. Qual Life Res (2011) 1.45
Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst (2013) 1.45
Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Stat Med (2007) 1.44
Enhancing cancer registry data to promote rational health system design. J Natl Cancer Inst (2008) 1.39
Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst (2012) 1.39
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum (2005) 1.37
Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer (2010) 1.34
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol (2013) 1.34
Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol (2011) 1.32
Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg (2011) 1.31
Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol (2013) 1.30
Geographic access and the use of screening mammography. Med Care (2010) 1.30
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. J Natl Compr Canc Netw (2009) 1.25
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res (2013) 1.21
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol (2004) 1.20
Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum (2007) 1.20
Building capacity to assess cancer care in the Medicaid population in New York State. Health Serv Res (2010) 1.19
Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol (2013) 1.16
Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst (2013) 1.16
Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst (2013) 1.14
Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care (2007) 1.09
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med (2011) 1.07
Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum (2008) 1.06
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. Ann Intern Med (2014) 1.05
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer. PLoS One (2012) 1.05
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer (2012) 1.05
Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer (2011) 1.04
Using propensity scores to estimate the cost-effectiveness of medical therapies. Stat Med (2006) 1.04
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst (2012) 1.04
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol (2012) 1.01
Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys (2006) 1.01
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol (2010) 1.01